Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics Inc.
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
1,94 €
3,55 %
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $1.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Chardan Capital from $25.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics (NASDAQ:IOVA) had its price target lowered by analysts at HC Wainwright from $20.00 to $9.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Neueste Beiträge
Morgan_Stanley in Hasbro Inc. diskutieren